Paraneoplastic Cerebellar Degeneration Secondary to BRAF Mutant Melanoma Metastasis from an Occult Primary Cancer
Open Access
- 11 June 2020
- journal article
- research article
- Published by S. Karger AG in Case Reports in Oncology
- Vol. 13 (2), 633-642
- https://doi.org/10.1159/000507729
Abstract
Melanoma metastasis from an unknown primary cancer has an incidence of 3.2% among melanoma patients. Furthermore, paraneoplastic neurological syndromes (PNS) are rare, occurring in 1–3% of patients with malignancies. Paraneoplastic cerebellar degeneration (PCD) is one of the classic PNS and is characterized by acute or subacute onset of ataxia and/or presence of onconeural antibodies. A 61-year-old male with ataxia, vertigo, and headache later developed dysarthria, multidirectional nystagmus, hyperactive delirium, auditory hallucinations, psychomotor agitation, and myoclonus. Toxicological, metabolic, infectious, and autoimmune etiologies were assessed and reported negative. An osteolytic lesion was observed in the right iliac crest via computed tomography (CT). A positron emission tomography-CT reported increased fluorodeoxyglucose uptake of a right iliac and right inguinal ganglion. After biopsy of the right inguinal ganglion, a BRAF mutation-positive melanoma metastasis from an occult primary cancer was diagnosed. Dermatologic, ophthalmologic, and endoscopic gastrointestinal assessment did not reveal a primary malignant melanoma. The patient’s movement disorders and neuropsychiatric symptoms improved with quetiapine, prednisone, azathioprine, and cyclophosphamide. Oncological management was conducted with MAPK pathway inhibitors (i.e., dabrafenib and trametinib). Movement disorders associated with neuropsychiatric symptoms are complex to diagnose. PNS are rare and often associated with antibodies against neural antigens expressed by the tumor. The case presented above describes a patient with a BRAF-positive malignant melanoma metastasis from an occult primary associated with PCD – to the best of our knowledge, the first reported in the literature.Keywords
This publication has 13 references indexed in Scilit:
- Diagnosis and management of progressive ataxia in adultsPractical Neurology, 2019
- Immune-mediated ataxiasPublished by Elsevier BV ,2018
- A case of acute paraneoplastic neurological syndrome in BRAF mutant metastatic melanomaMelanoma Research, 2016
- AtaxiaNeurologic Clinics, 2014
- Treatment of Paraneoplastic Cerebellar DegenerationCurrent Treatment Options in Neurology, 2013
- Screening for tumours in paraneoplastic syndromes: report of an EFNS Task ForceEuropean Journal of Neurology, 2010
- Malignant melanoma of unknown primary site. To make the long story short. A systematic review of the literatureCritical Reviews in Oncology/Hematology, 2010
- Paraneoplastic syndromes of the CNSThe Lancet Neurology, 2008
- Unusual magnetic resonance imaging and cerebrospinal fluid findings in paraneoplastic cerebellar degeneration: a sequential studyJournal of Neurology, Neurosurgery & Psychiatry, 2006
- Carbonic anhydrase–related protein VIII: Autoantigen in paraneoplastic cerebellar degenerationAnnals of Neurology, 2004